Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Ketoconazole on Tamsulosin PK
NCT02264171Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Apr 2008
- Primary completion
- Jun 2008
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of tamsulosin in benign prostatic hyperplasia (BPH) (2 arms), sponsored by Boehringer Ingelheim. Primary endpoints: Maximum measured concentration of Tamsulosin HCl in plasma and Area under the concentration-time curve of Tamsulosin HCl in plasma over the time interval from 0 extrapolated to infinity. Started Apr 2008; status: completed.
02
Drugs
tamsulosin
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT02264171.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02264171.